These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Guanyl nucleotide regulation of vasoactive intestinal peptide interaction with rat liver membranes. Ramírez-Cárdenas R, Prieto JC, Guerrero JM, Goberna R. Rev Esp Fisiol; 1981 Mar; 37(1):9-16. PubMed ID: 6264553 [Abstract] [Full Text] [Related]
6. Vasoactive intestinal peptide down-regulates the intrahepatic renin-angiotensin system in the anaesthetized rat. Ye VZ, Duggan KA. Clin Sci (Lond); 2000 Sep; 99(3):201-6. PubMed ID: 11787472 [Abstract] [Full Text] [Related]
7. Vasoactive intestinal peptide- and adrenocorticotropin-stimulated adenyl cyclase in cultured adrenal tumor cells: evidence for a specific vasoactive intestinal peptide receptor. Birnbaum RS, Alfonzo M, Kowal J. Endocrinology; 1980 Apr; 106(4):1270-5. PubMed ID: 6244149 [Abstract] [Full Text] [Related]
8. Glucose-targeted niosomes deliver vasoactive intestinal peptide (VIP) to the brain. Dufes C, Gaillard F, Uchegbu IF, Schätzlein AG, Olivier JC, Muller JM. Int J Pharm; 2004 Nov 05; 285(1-2):77-85. PubMed ID: 15488681 [Abstract] [Full Text] [Related]
9. Selectivity for binding of peptide analogs to vascular receptors for vasoactive intestinal peptide. Rorstad OP, Wanke I, Coy DH, Fournier A, Huang M. Mol Pharmacol; 1990 Jun 05; 37(6):971-7. PubMed ID: 2163020 [Abstract] [Full Text] [Related]
11. Hepatic clearance of somatostatin and gastrin-releasing peptide. Wolfe MM, Doyle JW, McGuigan JE. Life Sci; 1987 Jan 26; 40(4):335-42. PubMed ID: 2880271 [Abstract] [Full Text] [Related]
12. In vivo dynamical distribution of 131I-VIP in the rat studied by gamma-camera. Hassan M, Refai E, Andersson M, Schnell PO, Jacobsson H. Nucl Med Biol; 1994 Aug 26; 21(6):865-72. PubMed ID: 9234336 [Abstract] [Full Text] [Related]
13. The vasoactive intestinal peptide receptor turnover in pulmonary arteries indicates an important role for VIP in the rat lung circulation. Petkov V, Gentscheva T, Schamberger C, Haberl I, Artl A, Andreae F, Mosgoeller W. Ann N Y Acad Sci; 2006 Jul 26; 1070():481-3. PubMed ID: 16888213 [Abstract] [Full Text] [Related]
14. Preferential binding of vasoactive intestinal peptide to hepatic nonparenchymal cells. Gardner DF, Kilberg MS, Wolfe MM, McGuigan JE, Misbin RI. Am J Physiol; 1985 Jun 26; 248(6 Pt 1):G663-9. PubMed ID: 2988343 [Abstract] [Full Text] [Related]
16. [The temporal and spatial distribution of vasoactive intestinal peptide and its receptor in the development of airway hyperresponsiveness]. Ren YH, Qin XQ, Guan CX, Luo ZQ, Zhang CQ, Sun XH. Zhonghua Jie He He Hu Xi Za Zhi; 2004 Apr 26; 27(4):224-8. PubMed ID: 15144609 [Abstract] [Full Text] [Related]
17. Enteric release of vasoactive intestinal peptide after a peptone meal in the dog. Wolfe MM, Misbin RI, Gardner DF, McGuigan JE. Regul Pept; 1983 Jan 26; 5(2):103-9. PubMed ID: 6828775 [Abstract] [Full Text] [Related]
18. Release of vasoactive intestinal peptide in the central nervous system in man. Ebeid AM, Attia RR, Sundaram P, Fischer JE. Am J Surg; 1979 Jan 26; 137(1):123-7. PubMed ID: 31806 [Abstract] [Full Text] [Related]
19. Characteristics of the axonal transport of vasoactive intestinal polypeptide (VIP) in nerves of the cat. Lundberg JM, Fahrenkrug J, Brimijoin S. Acta Physiol Scand; 1981 Aug 26; 112(4):427-36. PubMed ID: 7315423 [Abstract] [Full Text] [Related]
20. Hepatic metabolism of vasoactive intestinal polypeptide (VIP) in the rat. Brook CW, Sewell RB, Shulkes A, Smallwood RA. Regul Pept; 1988 Apr 26; 20(4):311-22. PubMed ID: 3368582 [Abstract] [Full Text] [Related] Page: [Next] [New Search]